(Circulation. 2005;111:1869-1870.)
© 2005 American Heart Association, Inc.
Editorial |
From the Department of Family and Preventive Medicine, University of CaliforniaSan Diego School of Medicine, La Jolla, Calif.
Correspondence to Michael H. Criqui, MD, MPH, Professor, Dept of Family and Preventive Medicine, UCSD School of Medicine, 9500 Gilman Dr, 352 SCRB, La Jolla, CA 92093-0607. E-mail mcriqui@ucsd.edu
Key Words: Editorials obesity women risk factors cardiovascular diseases
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
A PubMed search in March 2005 with the key word "metabolic syndrome" yielded >10 000 references. Past labels for this disorder include "syndrome X," "deadly quartet," and "cardiovascular dysmetabolic syndrome."13 What is driving the current increased interest in the metabolic syndrome? Possibly the impetus comes from the dramatic increases in obesity in the United States and other developed countries.4 This pandemic has been blamed variously on fast food, high-fat foods, low-fat foods, overreliance on the automobile, television, the Internet, homes in which both parents work, unsafe streets, the disappearance of physical education from the K12 school curriculum, neighborhoods unsuitable for walking, and some or all of the above. An extensive and consistent body of evidence predicts that accompanying this increase in obesity will be increases in insulin resistance/diabetes, hypertension, hypertriglyceridemia, and decreased HDL cholesterol, as well as unfavorable changes in endothelial function and a host of inflammatory, thrombotic, and fibrinolytic factors. Thus, there is, indeed, reason for concern.
See p 1883
In this issue of Circulation, Tankó and colleagues5 attempt a simplification of the National Cholesterol Education ProgramAdult Treatment Panel III definition of metabolic syndrome (MS-NCEP) in postmenopausal women. They report that the combination of an enlarged waist and "elevated" triglycerides (EWET; enlarged waist, elevated triglycerides), as compared with the MS-NCEP, was equally prevalent, somewhat more predictive of cardiovascular disease (CVD) death, and somewhat more predictive of abdominal aortic calcium (AAC) progression. Their argument is carefully researched and presented but may strike the reader as
Related Article:
Circulation 2005 111: 1883-1890.
This article has been cited by other articles:
![]() |
F. J. Khawaja, K. R. Bailey, S. T. Turner, S. L. Kardia, T. H. Mosley Jr, and I. J. Kullo Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White Populations Mayo Clin. Proc., June 1, 2007; 82(6): 709 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Bloomgarden 2nd International Symposium on Triglycerides and HDL: Metabolic syndrome Diabetes Care, October 1, 2005; 28(10): 2577 - 2584. [Full Text] [PDF] |
||||
![]() |
G. Reaven Counterpoint: Just Being Alive Is Not Good Enough Clin. Chem., August 1, 2005; 51(8): 1354 - 1357. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |